KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Bortezomib, a therapeutic agent for multiple myeloma (MM) and mantle cell lymphoma, suppresses proteosomal degradation leading to substantial changes in cellular transcriptional programs and ultimately resulting in apoptosis. Transcriptional regulators required for bortezomib-induced apoptosis in MM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mannava, Sudha, Zhuang, DaZhong, Nair, Jayakumar R., Bansal, Rajat, Wawrzyniak, Joseph A., Zucker, Shoshanna N., Fink, Emily E., Moparthy, Kalyana C., Hu, Qiang, Liu, Song, Boise, Lawrence H., Lee, Kelvin P., Nikiforov, Mikhail A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286209/
https://ncbi.nlm.nih.gov/pubmed/22144178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-346676
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados